MCIM
ASND icon

Meadow Creek Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Meadow Creek Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$348K Buy
3,608
+440
+14% +$49.1K 0.01% 838
2019
Q2 		$365K Buy
3,168
+198
+7% +$23.7K 0.01% 825
2019
Q1 		$350K Sell
2,970
-1,166
-28% -$102K 0.01% 817
2018
Q4 		$259K Sell
4,136
-3,036
-42% -$191K 0.01% 863
2018
Q3 		$508K Buy
7,172
+220
+3% +$15.1K 0.01% 715
2018
Q2 		$462K Buy
6,952
+748
+12% +$49.2K 0.01% 684
2018
Q1 		$406K Buy
+6,204
New +$349K 0.01% 726

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Meadow Creek Investment Management's ASND Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Ascendis Pharma A/S (ASND) stake by 14% in Q3 2019, buying an estimated $49.1K and bringing the position to 3,608 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #838.

Meadow Creek Investment Management first reported a position in ASND in Q1 2018 and has held it in 7 quarters since. The position peaked at $508K in Q3 2018. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

  • Meadow Creek Investment Management held 3,608 shares of Ascendis Pharma A/S worth $348K as of Q3 2019.
  • Meadow Creek Investment Management bought 440 Ascendis Pharma A/S shares in Q3 2019, an estimated $49.1K.
  • Ascendis Pharma A/S made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #838 holding.
  • Meadow Creek Investment Management first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 7 quarters since.
  • Meadow Creek Investment Management's Ascendis Pharma A/S position peaked at $508K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.